Your browser doesn't support javascript.
Implementing daily chlorhexidine gluconate (CHG) bathing in VA settings: The human factors engineering to prevent resistant organisms (HERO) project.
Knobloch, Mary Jo; Musuuza, Jackson S; McKinley, Linda; Zimbric, Michele L; Baubie, Kelsey; Hundt, Ann Schoofs; Carayon, Pascale; Hagle, Mary; Pfeiffer, Christopher D; Galea, Marinella D; Crnich, Christopher J; Safdar, Nasia.
  • Knobloch MJ; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI; William S. Middleton Memorial Veterans Hospital, Madison, WI. Electronic address: Maryjo.Knobloch@va.gov.
  • Musuuza JS; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI; William S. Middleton Memorial Veterans Hospital, Madison, WI.
  • McKinley L; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI; William S. Middleton Memorial Veterans Hospital, Madison, WI.
  • Zimbric ML; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI.
  • Baubie K; William S. Middleton Memorial Veterans Hospital, Madison, WI.
  • Hundt AS; Center for Quality and Productivity Improvement, University of Wisconsin-Madison, Madison, WI; Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI.
  • Carayon P; Center for Quality and Productivity Improvement, University of Wisconsin-Madison, Madison, WI; Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI.
  • Hagle M; Clement J. Zablocki VA Medical Center, Milwaukee, WI.
  • Pfeiffer CD; VA Portland HealthCare System, Portland, OR; Department of Medicine, Oregon Health and Science University, Portland, OR.
  • Galea MD; James J Peters Medical Center, Bronx, NY; Icahn School of Medicine at Mount Sinai, Department of Rehabilitation and Human Performance, New York, NY; New York Presbyterian Hospital, Columbia University School of Medicine, Department of Medicine, New York, NY.
  • Crnich CJ; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI; William S. Middleton Memorial Veterans Hospital, Madison, WI.
  • Safdar N; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI; William S. Middleton Memorial Veterans Hospital, Madison, WI.
Am J Infect Control ; 49(6): 775-783, 2021 06.
Article in English | MEDLINE | ID: covidwho-1300594
ABSTRACT

BACKGROUND:

Daily use of chlorhexidine gluconate (CHG) has been shown to reduce risk of healthcare-associated infections. We aimed to assess moving CHG bathing into routine practice using a human factors approach. We evaluated implementation in non-intensive care unit (ICU) settings in the Veterans Health Administration.

METHODS:

Our multiple case study approach included non-ICU units from 4 Veterans Health Administration settings. Guided by the Systems Engineering Initiative for Patient Safety, we conducted focus groups and interviews to capture barriers and facilitators to daily CHG bathing. We measured compliance using observations and skin CHG concentrations.

RESULTS:

Barriers to daily CHG include time, concern of increasing antibiotic resistance, workflow and product concerns. Facilitators include engagement of champions and unit shared responsibility. We found shortfalls in patient education, hand hygiene and CHG use on tubes and drains. CHG skin concentration levels were highest among patients from spinal cord injury units. These units applied antiseptic using 2% CHG impregnated wipes vs 4% CHG solution/soap.

DISCUSSION:

Non-ICUs implementing CHG bathing must consider human factors and work system barriers to ensure uptake and sustained practice change.

CONCLUSIONS:

Well-planned rollouts and a unit culture promoting shared responsibility are key to compliance with daily CHG bathing. Successful implementation requires attention to staff education and measurement of compliance.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cross Infection / Anti-Infective Agents, Local Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Humans Language: English Journal: Am J Infect Control Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Cross Infection / Anti-Infective Agents, Local Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Humans Language: English Journal: Am J Infect Control Year: 2021 Document Type: Article